Zobrazeno 1 - 10
of 713
pro vyhledávání: '"Prognostic analysis"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Multiple myeloma (MM) is a common hematological malignancy, and its prognostic factors have been extensively studied. Progression of disease within 24 months (POD24) suggests a poor prognosis in many malignancies, but is rarely mentioned in
Externí odkaz:
https://doaj.org/article/34959bd9d7a147c79952a78cfcb64dfd
Publikováno v:
Alexandria Engineering Journal, Vol 102, Iss , Pp 264-278 (2024)
Ovarian cancer ranks among the deadliest gynecological malignancies, with high-grade serous adenocarcinoma (HGSA) constituting 75 % of ovarian cancer cases and accounting for 80 %–90 % of ovarian cancer-related fatalities. Accurate prognosis predic
Externí odkaz:
https://doaj.org/article/4a7494b4e2094da595c3a5bf5a71b860
Publikováno v:
International Journal of Ophthalmology, Vol 17, Iss 8, Pp 1423-1430 (2024)
AIM: To explore the prognostic factors for lacrimal gland adenoid cystic carcinoma (LGACC) in Chinese patients. METHODS: Clinical and histopathological data were reviewed in patients with pathologically confirmed LGACC. Local recurrence, metastasis,
Externí odkaz:
https://doaj.org/article/81d9eab2d8664a50a105ed6619a82b89
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Accurate prognostic assessment is vital for the personalized treatment of endometrial cancer (EC). Although radiomics models have demonstrated prognostic potential in EC, the impact of region of interest (ROI) delineation strategi
Externí odkaz:
https://doaj.org/article/242e6acbd1fe49ed948655feb72f7440
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveDiagnosis and treatment of gastroenteropancreatic high-grade neuroendocrine neoplasms (GEP-HG-NENs), particularly G3 well-differentiated neuroendocrine tumours (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) relies on histo
Externí odkaz:
https://doaj.org/article/931f9f46d4fc4808ba1b8610da5b211a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe Nottingham prognostic index (NPI) has been shown to negatively impact survival in breast cancer (BC). However, its ability to predict the locoregional recurrence (LRR) of BC remains still unclear. This study aims to determine whether a
Externí odkaz:
https://doaj.org/article/5e29b1faf1ee482dbf3d9a3c7651c63f
Autor:
Kazuhiko Hayashi, Osamu Suzuki, Yushi Wakisaka, Koji Ichise, Hirofumi Uchida, Makoto Anzai, Azusa Hasegawa, Yuji Seo, Shinichi Shimizu, Takayoshi Ishii, Teruki Teshima, Jiro Fujimoto, Kazuhiko Ogawa
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Radiation-induced liver damage (RILD) occasionally occurs following carbon-ion radiotherapy (CIRT) for liver tumors, such as hepatocellular carcinoma (HCC), in patients with impaired liver function disease. However, the associated
Externí odkaz:
https://doaj.org/article/03a9d0bfd88e4c4f81b65bdc5e51250b
Publikováno v:
Romanian Journal of Medical Practice, Vol 19, Iss 1, Pp 22-29 (2024)
Objectives. The aim of this study was to explore the clinicopathological characteristics, prognostic factors, recurrence patterns and survival analysis of triple negative breast cancer patients compared to non-triple negative breast cancer patients.
Externí odkaz:
https://doaj.org/article/1653d7ed360e46d38b91d3ea2b35da21
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Hyponatremia, a prevalent electrolyte imbalance among tumor patients, has often been overlooked regarding its prognostic significance for immunotherapy. In this study, we delved into the prognostic ramifications of hyponatremia in advanced gastric ca
Externí odkaz:
https://doaj.org/article/a5295c601de442538dc22945e42c3ca4
Autor:
Huimin Chen, Ruixue Ma, Qianqian Zhang, Fengyi Lu, Yuhan Ma, Jingxin Zhou, Jiang Cao, Kunming Qi, Zhiling Yan, Wei Sang, Feng Zhu, Haiying Sun, Depeng Li, Zhenyu Li, Hai Cheng, Kailin Xu, Wei Chen
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTBackground: Peripheral T-cell lymphomas (PTCL) are an aggressive group of mature T-cell neoplasms, often associated with poor outcomes, in part, due to frequent relapsed/refractory disease. The objective of this study was to assess the progno
Externí odkaz:
https://doaj.org/article/ada56b4285714342bd2679a9915c325d